Your browser doesn't support javascript.
loading
Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort.
Stott-Miller, Marni; Müllerová, Hana; Miller, Bruce; Tabberer, Maggie; El Baou, Céline; Keeley, Tom; Martinez, Fernando J; Han, Meilan; Dransfield, Mark; Hansel, Nadia N; Cooper, Christopher B; Woodruff, Prescott; Ortega, Victor E; Comellas, Alejandro P; Paine Iii, Robert; Kanner, Richard E; Anderson, Wayne; Drummond, M Bradley; Kim, Victor; Tal-Singer, Ruth; Lazaar, Aili L.
Affiliation
  • Stott-Miller M; GSK R&D, Epidemiology: Value, Evidence and Outcomes, Uxbridge, UK.
  • Müllerová H; AstraZeneca, Cambridge, UK.
  • Miller B; GSK R&D, Discovery Medicine, Collegeville, PA, USA.
  • Tabberer M; GSK R&D Patient-Centred Outcomes: Value, Evidence and Outcomes, Uxbridge, UK.
  • El Baou C; CEBSTAT Consultancy Ltd, London, UK.
  • Keeley T; GSK R&D Patient-Centred Outcomes: Value, Evidence and Outcomes, Uxbridge, UK.
  • Martinez FJ; Cornell Medical College, New York, NY, USA.
  • Han M; Division of Pulmonary and Critical Care at the University of Michigan, Ann Arbor, MI, USA.
  • Dransfield M; Children's of Alabama, Children's Health Research Unit/University of Alabama, Birmingham, AB, USA.
  • Hansel NN; Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, USA.
  • Cooper CB; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Woodruff P; UCSF Department of Medicine, San Francisco, CA, USA.
  • Ortega VE; Wake Forest School of Medicine, Winston Salem, NC, USA.
  • Comellas AP; Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
  • Paine Iii R; Division of Pulmonary and Critical Care Medicine, University of Utah, Salt Lake City, UT, USA.
  • Kanner RE; Division of Pulmonary and Critical Care Medicine, University of Utah, Salt Lake City, UT, USA.
  • Anderson W; Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Drummond MB; Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Kim V; Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Tal-Singer R; COPD Foundation, Washington, DC, USA.
  • Lazaar AL; GSK R&D, Discovery Medicine, Collegeville, PA, USA.
Int J Chron Obstruct Pulmon Dis ; 15: 2467-2476, 2020.
Article de En | MEDLINE | ID: mdl-33116463
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Bronchite chronique / Broncho-pneumopathie chronique obstructive Type d'étude: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limites: Female / Humans / Male Langue: En Journal: Int J Chron Obstruct Pulmon Dis Année: 2020 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Nouvelle-Zélande
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Bronchite chronique / Broncho-pneumopathie chronique obstructive Type d'étude: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limites: Female / Humans / Male Langue: En Journal: Int J Chron Obstruct Pulmon Dis Année: 2020 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Nouvelle-Zélande